This review provides a brief update about the strategies that have been developed for the hipoallergenic immunotherapy against latex allergens. Thus, recombinant mutants, chemically modified molecules, anti IgE monoclonal antibodies and T-cell epitope-based peptides have been used. Additionally, recent finds that show the importance of dendritic cells and their potential applicability to latex allergens are included.
Escobar A., A. ., Guzmán M., M. A. ., & Aguillón G., J. C. . (2007). Alergia al látex. Avances en el desarrollo de inmunoterapias hipoalergénicas específicas. Revista Hospital Clínico Universidad De Chile, 18(3), pp. 257–64. https://doi.org/10.5354/2735-7996.2007.77645
